Funds · AIMT

Who owns AIMT?

No institutional manager reported a Aimmune Therapeutics, Inc. position in the latest Form 13F data we have. 13F covers US-listed shares held by managers with at least $100 million in such securities.

AIMT news and filings · Top funds